About Course #Y8028
Start Date: January 5, 2017
Expiration Date: January 5, 2020
Treatment guidelines for diabetes recommend a patient-centered approach to therapy beginning with lifestyle changes (diet, exercise, and weight loss). Both insulin and non-insulin pharmacotherapies are available to help decrease blood glucose levels, reduce the risk of short- and long-term complications, and improve the patient's quality of life.
Many new pharmacotherapies have become available in recent years. The variety of options is ideal for patients with diabetes, but this vast array of choices may make treating diabetes daunting for health-care providers. In addition, new guidelines for the treatment of diabetes have been released by both the American Diabetes Association and the American Association of Clinical Endocrinologists. In order to effectively manage patients with diabetes, it is important to stay current with the standard of care for treatment of diabetes and the therapeutic options available. This course reviews the available insulin formulations and their role in treating type 1 and 2 diabetes.
Universal Activity Number (UAN) - 0607-0000-17-016-H01-P
Type of Activity - Knowledge
Topic Designator - 01 - Disease State Management/Drug Therapy
- Compare and contrast the time-action profiles and usual uses of insulin formulations.
- Identify contraindications to therapy or adverse events that patients may experience when taking insulin.
- Recommend a starting insulin regimen for a patient newly diagnosed with diabetes.
About the Author
Dhiren K. Patel, PharmD, CDE, BC-ADM, BCACP, is an associate professor of pharmacy practice in the School of Pharmacy - Boston at MCPHS University (formerly Massachusetts College of Pharmacy and Health Sciences). He also maintains a clinical practice site with the VA Boston Healthcare System, where he functions as a mid-level provider for a variety of chronic diseases such as diabetes, hypertension, dyslipidemia, and obesity. He earned his PharmD from MCPHS University and received his postdoctoral residency training at the VA Boston Healthcare System. He is also board-certified in advanced diabetes management (BC-ADM), as an ambulatory care pharmacist (BCACP), and as a diabetes educator (CDE).
- Courses must be completed on or before the expiration date noted in the course description above.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.